Overview

An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos

Status:
Completed
Trial end date:
2016-05-12
Target enrollment:
Participant gender:
Summary
This post-marketing, multi-center prospective study will be conducted in a open-label, non-interventional setting, for women seeking fertility treatment and will describe morphokinetic de-selection parameters in human embryos.
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Menotropins